HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

YIL 781

an appetite suppressant and weight loss promoter; structure in first source

Also Known As:

YIL-781; YIL781

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - YIL 781: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - Quinazolinones: 124
        YIL 781: 2

Experts

1.	Ben Haj Salah, Khoubaib: 1 article (05/2019)
2.	Buckinx, An: 1 article (05/2019)
3.	Cottone, Eleonora: 1 article (05/2019)
4.	De Bundel, Dimitri: 1 article (05/2019)
5.	Fehrentz, Jean-Alain: 1 article (05/2019)
6.	Kooijman, Ron: 1 article (05/2019)
7.	Pierre, Anouk: 1 article (05/2019)
8.	Smolders, Ilse: 1 article (05/2019)
9.	Van Den Herrewegen, Yana: 1 article (05/2019)
10.	Aguinaga, David: 1 article (02/2019)

Related Diseases

1.	Seizures (Absence Seizure) 05/20/2019 - "Mice treated with JMV-1843 had fewer and less severe seizures compared to saline-treated controls, while mice treated with YIL781 experienced longer and more severe seizures. "
2.	Neuroblastoma 02/01/2019 - "Moreover, in transfected HEK-293T and neuroblastoma SH-SY5Y cells, and in primary neuronal cultures, pretreatment with cocaine or a σ1R agonist inhibited ghrelin-mediated signaling, in a similar manner as the GHS-R1a antagonist YIL-781. "

Related Drugs and Biologics

1.	Ghrelin Receptors
2.	Ghrelin
3.	Cocaine (Cocaine HCl)
4.	macimorelin